Published in Circulation on July 01, 1997
Exercise training normalizes ACE and ACE2 in the brain of rabbits with pacing-induced heart failure. J Appl Physiol (1985) (2010) 1.16
Left ventricular assist device unloading effects on myocardial structure and function: current status of the field and call for action. Curr Opin Cardiol (2011) 1.04
Why are mineralocorticoid receptor antagonists cardioprotective? Naunyn Schmiedebergs Arch Pharmacol (2006) 0.97
Cardiovascular effects of losartan and its relevant clinical application. Curr Med Chem (2009) 0.84
Endogenous angiotensinergic system in neurons of rat and human trigeminal ganglia. Regul Pept (2009) 0.84
Effects of nicotine on cardiovascular remodeling in a mouse model of systemic hypertension. Cardiovasc Toxicol (2013) 0.76
Adipose tissue (P)RR regulates insulin sensitivity, fat mass and body weight. Mol Metab (2016) 0.75
International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev (1994) 7.11
Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology (1986) 5.83
The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med (2000) 4.81
A clinical prediction rule for renal artery stenosis. Ann Intern Med (1998) 4.32
Cystatin for estimation of glomerular filtration rate? Lancet (2000) 2.80
Contribution of adverse drug reactions to hospital admission of older patients. Age Ageing (2000) 2.29
Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation (1995) 2.25
Selective vasoconstriction in carotid vascular bed by methysergide: possible relevance to its antimigraine effect. Eur J Pharmacol (1974) 2.04
Clinical validation of renin monoclonal antibody-based sandwich assays of renin and prorenin, and use of renin inhibitor to enhance prorenin immunoreactivity. Clin Chem (1996) 2.02
Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist. Br Med J (Clin Res Ed) (1982) 2.02
Cardiac renin and angiotensins. Uptake from plasma versus in situ synthesis. Hypertension (1994) 1.87
Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521. Br J Clin Pharmacol (1982) 1.81
Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system. Br J Ophthalmol (1996) 1.74
Renal artery stenosis and hypertension. Lancet (1994) 1.67
5-HT, alpha-adrenoceptors, and blood pressure. Effects of ketanserin in essential hypertension and autonomic insufficiency. Hypertension (1984) 1.58
Volume regulation in children with early relapse of minimal-change nephrosis with or without hypovolaemic symptoms. Lancet (1995) 1.56
Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy. Drugs (2000) 1.54
Ergotamine in the acute treatment of migraine: a review and European consensus. Brain (2000) 1.52
How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta-adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanism. Br J Clin Pharmacol (1982) 1.51
Pindolol acts as beta-adrenoceptor agonist in orthostatic hypotension: therapeutic implications. Br Med J (Clin Res Ed) (1981) 1.51
Do older hospital patients recognize adverse drug reactions? Age Ageing (2000) 1.49
The effects of mianserin hydrochloride on the vascular responses evoked by 5-hydroxytryptamine and related vasoactive substances. Eur J Pharmacol (1971) 1.49
Contrasting response to cyclosporin in refractory nephrotic syndrome. Clin Nephrol (1989) 1.48
Craniovascular selectivity of eletriptan and sumatriptan in human isolated blood vessels. Neurology (2000) 1.47
Free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 (IGFBP-1), and IGFBP-3 and their relationships to the presence of diabetic retinopathy and glomerular hyperfiltration in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1997) 1.45
Porcine carotid vascular effects of eletriptan (UK-116,044): a new 5-HT1B/1D receptor agonist with anti-migraine activity. Naunyn Schmiedebergs Arch Pharmacol (1998) 1.42
Bradykinin-induced contraction of human peripheral airways mediated by both bradykinin beta 2 and thromboxane prostanoid receptors. Am J Respir Crit Care Med (1994) 1.41
[Monotherapy with antihypertensive drugs: can a choice be made?]. Ned Tijdschr Geneeskd (1992) 1.40
Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. Circulation (1997) 1.40
[Improper equalization of sumatriptan with ergotamine and dihydroergotamine in the Drug Equivalency System]. Ned Tijdschr Geneeskd (1993) 1.40
Support for adrenaline-hypertension hypothesis: 18 hour pressor effect after 6 hours adrenaline infusion. Lancet (1988) 1.40
[Hypertension caused by arterial fibromuscular dysplasia]. Ned Tijdschr Geneeskd (1994) 1.39
Coronary side-effect potential of current and prospective antimigraine drugs. Circulation (1998) 1.36
Intrarenal angiotensin II: interstitial and cellular levels and site of production. Kidney Int (2001) 1.36
Angiotensin levels in the eye. Invest Ophthalmol Vis Sci (1994) 1.36
Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy. J Clin Endocrinol Metab (1989) 1.35
Opposite effects of captopril on angiotensin I-converting enzyme 'activity' and 'concentration'; relation between enzyme inhibition and long-term blood pressure response. Clin Sci (Lond) (1981) 1.31
Mediation of 5-hydroxytryptamine-induced tachycardia in the pig by the putative 5-HT4 receptor. Br J Pharmacol (1990) 1.31
Computer programs for the radioactive microsphere technique. Determination of regional blood flows and other haemodynamic variables in different experimental circumstances. Comput Programs Biomed (1980) 1.29
Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans. J Hypertens (1998) 1.28
Adverse drug reactions in elderly patients as contributing factor for hospital admission: cross sectional study. BMJ (1997) 1.27
Angiotensin I-to-II conversion in the human renal vascular bed. J Hypertens (1998) 1.26
5-Carboxamide tryptamine, a compound with high affinity for 5-hydroxytryptamine1 binding sites, dilates arterioles and constricts arteriovenous anastomoses. Br J Pharmacol (1985) 1.25
Congenital dopamine-beta-hydroxylase deficiency. A novel orthostatic syndrome. Lancet (1987) 1.25
5-Hydroxytryptamine-induced tachycardia in the pig: possible involvement of a new type of 5-hydroxytryptamine receptor. Br J Pharmacol (1988) 1.25
On serotonin and migraine: a clinical and pharmacological review. Cephalalgia (1993) 1.23
Inactive renin in human plasma. Lancet (1976) 1.22
The effect of ergotamine on tissue blood flow and the arteriovenous shunting of radioactive microspheres in the head. Br J Pharmacol (1978) 1.22
Is low-renin hypertension a stage in the development of essential hypertension or a diagnostic entity? Lancet (1975) 1.18
Effects of an angiotensin-converting enzyme inhibitor (captopril) on blood pressure in anephric subjects. Br Med J (1980) 1.17
Angiotensin production by the heart: a quantitative study in pigs with the use of radiolabeled angiotensin infusions. Circulation (1998) 1.16
Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone. Br Heart J (1983) 1.15
Redistribution by 5-hydroxytryptamine of carotid arterial blood at the expense of arteriovenous anastomotic blood flow. J Physiol (1982) 1.15
Mechanism of selective cardiac vagolytic action of pancuronium bromide. Specific blockade of cardiac muscarinic receptors. Eur J Pharmacol (1970) 1.15
AT1 receptor A/C1166 polymorphism contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy. Hypertension (1998) 1.15
Increase in serum prorenin precedes onset of microalbuminuria in patients with insulin-dependent diabetes mellitus. Diabetologia (1999) 1.14
Oxidative epithelial damage produces hyperresponsiveness of human peripheral airways. Am J Respir Crit Care Med (1994) 1.14
Characterization of putative 5-HT7 receptors mediating tachycardia in the cat. Br J Pharmacol (1997) 1.14
Mannose 6-phosphate receptor-mediated internalization and activation of prorenin by cardiac cells. Hypertension (1997) 1.14
Angiotensin II type 1 (AT1) receptor-mediated accumulation of angiotensin II in tissues and its intracellular half-life in vivo. Hypertension (1997) 1.13
Role of some biogenic substances in migraine and relevant mechanism in antimigraine action of ergotamine--studies in an experimental model for migraine. Headache (1974) 1.12
Hemodynamic changes during long-term thiazide treatment of essential hypertension in responders and nonresponders. Clin Pharmacol Ther (1980) 1.12
Antimigraine drug sumatriptan increases blood flow velocity in large cerebral arteries during migraine attacks. Neurology (1992) 1.10
Analysis of the heart rate effects of 5-hydroxytryptamine in the cat; mediation of tachycardia by 5-HT1-like receptors. Naunyn Schmiedebergs Arch Pharmacol (1985) 1.10
Reduction of blood pressure with oral magnesium supplementation in women with mild to moderate hypertension. Am J Clin Nutr (1994) 1.09
Activation of inactive plasma renin by plasma and tissue kallikreins. Clin Sci (Lond) (1979) 1.09
Effects of 10 different beta-adrenoceptor antagonists on hemodynamics, plasma renin activity, and plasma norepinephrine in hypertension: the key role of vascular resistance changes in relation to partial agonist activity. J Cardiovasc Pharmacol (1983) 1.08
Identification and quantification of renin and prorenin in the bovine eye. Endocrinology (1990) 1.08
Sympathetic and parasympathetic components of reflex cardiostimulation during vasodilator treatment of hypertension. Br J Clin Pharmacol (1980) 1.08
Control of enzymatically inactive renin in man under various pathological conditions: implications for the interpretation of renin measurements in peripheral and renal venous plasma. Clin Sci Mol Med (1978) 1.07
Cardiovascular profile of pimobendan, a benzimidazole-pyridazinone derivative with vasodilating and inotropic properties. Eur J Pharmacol (1986) 1.06
Effects of selective and nonselective beta-agonists on plasma potassium and norepinephrine. J Cardiovasc Pharmacol (1984) 1.06
Plasma thyroxine, 3,3',5-triiodothyronine and 3,3',5'-triiodothyronine during beta-adrenergic blockade in hyperthyroidism. J Clin Endocrinol Metab (1977) 1.06
Sodium restriction and potassium supplementation in young people with mildly elevated blood pressure. J Hypertens (1987) 1.06
Further characterization, by use of tryptamine and benzamide derivatives, of the putative 5-HT4 receptor mediating tachycardia in the pig. Br J Pharmacol (1991) 1.05
Splint renal function after captopril in unilateral renal artery stenosis. Br Med J (Clin Res Ed) (1984) 1.04